Immunic, Inc. (IMUX)
7.72
-0.08
(-0.96%)
USD |
NASDAQ |
Oct 30, 09:39
Immunic Market Cap : 105.34M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 106.36M |
| October 28, 2026 | 108.88M |
| October 27, 2026 | 103.83M |
| October 26, 2026 | 99.33M |
| October 23, 2026 | 101.11M |
| October 22, 2026 | 98.51M |
| October 21, 2026 | 102.06M |
| October 20, 2026 | 101.11M |
| October 19, 2026 | 95.38M |
| October 16, 2026 | 95.10M |
| October 15, 2026 | 96.88M |
| October 14, 2026 | 90.87M |
| October 13, 2026 | 94.01M |
| October 12, 2026 | 108.47M |
| October 09, 2026 | 111.75M |
| October 08, 2026 | 103.15M |
| October 07, 2026 | 104.11M |
| October 06, 2026 | 106.70M |
| October 05, 2026 | 110.11M |
| October 02, 2026 | 108.61M |
| October 01, 2026 | 117.89M |
| September 30, 2026 | 126.89M |
| September 29, 2026 | 121.57M |
| September 28, 2026 | 129.76M |
| September 25, 2026 | 127.51M |
| Date | Value |
|---|---|
| September 24, 2026 | 127.17M |
| September 23, 2026 | 127.85M |
| September 22, 2026 | 147.91M |
| September 21, 2026 | 147.77M |
| September 18, 2026 | 144.90M |
| September 17, 2026 | 141.22M |
| September 16, 2026 | 138.08M |
| September 15, 2026 | 141.49M |
| September 14, 2026 | 153.23M |
| September 11, 2026 | 155.82M |
| September 10, 2026 | 161.55M |
| September 09, 2026 | 166.33M |
| September 08, 2026 | 173.83M |
| September 04, 2026 | 178.88M |
| September 03, 2026 | 174.10M |
| September 02, 2026 | 194.30M |
| September 01, 2026 | 198.94M |
| August 31, 2026 | 215.58M |
| August 28, 2026 | 210.13M |
| August 27, 2026 | 222.41M |
| August 26, 2026 | 225.00M |
| August 25, 2026 | 224.04M |
| August 24, 2026 | 224.59M |
| August 21, 2026 | 225.13M |
| August 20, 2026 | 219.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.615B |
| Sionna Therapeutics, Inc. | 180.66M |
| Alnylam Pharmaceuticals, Inc. | 23.97B |
| Anika Therapeutics, Inc. | 291.62M |
| Savara, Inc. | 1.020B |
Market Cap Related Metrics
| Price to Book Value | 0.8257 |
| Price | 7.72 |
| Earnings Yield | -62.25% |